Bioinformatician / Engineer / Researcher / Scientist
Bioinformatician within large metastasis research consortium Full-time
The Transregio TRR 305 is a DFG-funded collaborative research consortium between the Universities of Regensburg, Erlangen, and the Fraunhofer Society (https://www.experimentelle-medizin.de/verbundforschung). It focuses on the mechanisms of early metastasis formation with the goal to identify novel therapies to effectively treat systemic cancer. It will become one of the largest metastasis research consortia in Europe with an expected duration of 12 years. It comprises 18 research and three core projects. For the core project Z01, we are looking for a
Bioinformatician (m/f/d)
based in Erlangen to support project partners in the bioinformatics analysis of omics data.
Your tasks will include:
- setting up and maintaining pipelines for sequencing data analyses (bulk and single-cell RNA-Seq, ATAC-Seq, ChIP-Seq);
- closely interacting with CRC project partners to support post-processing analyses of omics data (e.g. functional enrichment, visualisation and interpretation of results, data integration with publicly available datasets, preparation of publication-ready figures);
Your qualifications:
- academic degree (MSc/PhD) in bioinformatics, computational or life sciences. A PhD is preferred but not essential.
- prior experience in the analysis of next-generation sequencing data is advantageous;
- familiarity with working in a Linux/Unix environment;
- strong programming skills (e.g. Python, Perl, R);
- excellent communication skills and fluency in English.
Applications should be sent to Dr. Fulvia Ferrazzi, Institute of Pathology, FAU Erlangen-Nürnberg, and include a letter of interest, a CV (containing a list of publications, if applicable), a brief description of research experience, as well as contact information of two references.
The position is available for 4 years, with the possibility of extension. The starting date is the earliest possible timepoint. Deadline for applications is 05.03.2021